TCR Annual Report (2016)
AME Publishing Company successfully closed Series A funding of 4 million USD
It is great to announce that Translational Cancer Research (TCR) gains its 2015 impact factor: 1.757
TCR Annual Report of 2015
We sincerely welcome you to visit our booth “AME Publishing Company” at No. 300 in Hall A. Look forward to meeting you in San Antonio!
Translational Cancer Research is indexed in SCIE
With pleasure, we are here to announce that Translational Cancer Research (TCR) has been accepted for inclusion in Scopus.
Prestigious editorial board members of Translational Cancer Research (TCR) recommend the journal according to their knowledge to TCR and their personal interaction with it. The editorial team appreciate supports from the Editorial Board Members.
The editorial team of Translational Cancer Research is attending the following conferences in 2014. Your joining us will be warmly welcomed.
Guest Editors: Frederik Wenz and Elena Sperk, University Medical Center Mannheim, Department of Radiation Oncology, University of Heidelberg, Germany
Guest Editor: Catherine Frenette, Scripps Green Hospital, La Jolla, CA 92037, USA
Guest Editors: Dung-Tsa Chen and Ann Chen, Moffitt Cancer Center & Research Institute, Tampa, USA
Guest Editors: Daohong Zhou, University of Arkansas for Medical Sciences, USA; Chuanyuan Li, Duke University Medical Center, USA
The editorial team of Translational Cancer Research will attend the ASTRO 2013 Annual Meeting at Georgia World Congress Center, Atlanta, September 22nd to 25th.
TCR will exhibit at ASCO’s 49th Annual Meeting at McCormick Place in Chicago, Illinois, from May 31 to June 4, 2013.
Cancer is one of the leading causes of death worldwide. According to the World Health Organization (WHO), there are about 13 million new cases per year, and 8 million deaths annually, which account for 13% of all human deaths. This mortality figure is projected to rise to 12 million by 2030.
1 - 17 of 17 Items